Masimo (NSDQ:MASI) shares are down today after a slide on third-quarter profits, despite an increase in sales revenue. Irvine, Calif.-based Masimo posted profits of $49.1 million, or 86¢ per share, on sales of $228.9 million for the three months ended Sept. 30, for a bottom-line slide of -14.1% on revenue growth of 13.6%. Adjusted to exclude […]
Respiratory
ResMed surges on fiscal Q1 beats
ResMed (NYSE:RMD) shares surged in premarket trading today after the respiratory company posted fiscal first-quarter numbers that topped the consensus forecast. San Diego-based ResMed posted profits of $120.1 million, or 83¢ per share, on sales of $681.1 million for the three months ended Sept. 30, for a 13.6% bottom-line gain on sales growth of 15.8%. Adjusted […]
Auris Health touts FIH results for Monarch robot-assisted bronchoscopy device
Johnson & Johnson (NYSE:JNJ) subsidiary Auris Health said today that a study of its Monarch robot-assisted bronchoscopy device reached its primary effectiveness endpoint in nearly all procedures. The Benefit study assessed the platform’s ability to aid in the diagnosis of peripheral pulmonary lesions ranging from 1cm to 5cm. The Monarch platform localized targeted nodules using […]
Teleflex says infant breathing device it distributes is recalled
Teleflex (NYSE:TFX) today announced a recall of a device used to help newborns with infant respiratory distress syndrome to breathe. Teleflex is one of the U.S. distributors of the device, the Babi.Plus 12.5 cm H2O pressure relief manifold, manufactured by GaleMed. The FDA has designated the recall as Class I. The recall began June 14 […]
CSA Medical touts one-year feasibility data for RejuvenAir bronchitis device
CSA Medical said today that results of its feasibility study into the RejuvenAir metered cryospray system showed improved quality of life in patients who have chronic obstructive pulmonary disease with chronic bronchitis. The one-year study treated 35 patients using metered cryospray with the RejuvenAir system that is designed to apply spray-liquid nitrogen at -196◦C in […]
GSK seeks additional asthma indication for Trelegy Ellipta
GlaxoSmithKline (NYSE:GSK) and Innoviva (NSDQ:INVA) said yesterday that they filed a supplemental New Drug Application with the FDA, seeking an additional indication for GSK’s Trelegy Ellipta inhaler for the treatment of asthma in adults. The once-daily, single-inhaler triple-therapy device received FDA approval for the treatment of chronic obstructive pulmonary disease in September 2017. Trelegy Ellipta has not […]
Sleep Data, BetterNight raise $6m
Sleep Data said it raised $6 million to back the market expansion of its BetterNight virtual care platform. BetterNight, which launched in 2018, is designed to access care through telemedicine and remote patient monitoring to deliver lower cost of care and improved outcomes. San Diego-based BetterNight will put the funding toward market expansion of the […]
Boehringer Ingelheim touts Spiolto Respimat inhaler data
Boehringer Ingelheim said yesterday that results from a study of its Spiolto Respimat inhaler showed benefits including improving symptoms and lung function in treating chronic obstructive pulmonary disease. The Spiolto Respimat is a soft-mist inhaler designed for the treatment of airflow obstruction in patients with COPD. A pooled analysis exploring COPD treatment with the tiotropium-based […]
Convexity Scientific raises $4m Series B for Flyp nebulizer
Convexity Scientific said yesterday that it closed a Series B financing round worth nearly $4 million ahead of the launch of its Flyp nebulizer. Fairfield, Conn.-based Convexity’s funding was led by HighCape Capital with participation from Connecticut Innovations, Benslie International and Stonehenge Capital, according to a news release. The company said the funding is earmarked […]
More reimbursement wins for Inspire Medical Systems
Inspire Medical Systems (NYSE:INSP) said yesterday that it received two additional draft Local Coverage Determinations for its minimally invasive therapy for sleep apnea. The latest proposals were issued by National Government Services and CGS Administrators, which represent a combined 12 states. The companies have different public comment periods, with NGS’s running from Sept. 26 to Nov. […]
Body Vision Medical raises $20m for lung diagnostic tech
Body Vision Medical said today that it closed $20 million in Series C funding, which is earmarked for its LungVision 2.0 platform. The Ramat Ha Sharon, Israel-based company said the money will be used to streamline commercialization and manufacturing activities for the LungVision 2.0. LungVision 2.0, which was cleared by the FDA in May, features […]